Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
Rationale In depressive disorders, one of the mechanisms proposed for antidepressant
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
V Di Liberto, M Frinchi, V Verdi, A Vitale, F Plescia… - …, 2016 - infona.pl
Rationale In depressive disorders, one of the mechanisms proposed for antidepressant
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
[PDF][PDF] Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
V Di Liberto, M Frinchi, V Verdi, A Vitale… - …, 2017 - academia.edu
Rationale In depressive disorders, one of the mechanisms proposed for antidepressant
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
V Di Liberto, M Frinchi, V Verdi, A Vitale… - …, 2017 - search.ebscohost.com
Rationale: In depressive disorders, one of the mechanisms proposed for antidepressant
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
V Di Liberto, M Frinchi, V Verdi, A Vitale… - …, 2017 - search.proquest.com
Objectives Here, we aimed to explore (a) whether Oxo exerts anxiolytic effect in the rat
model of anxiety-depression-like behavior induced by chronic restraint stress (CRS), and (b) …
model of anxiety-depression-like behavior induced by chronic restraint stress (CRS), and (b) …
Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
V Di Liberto, M Frinchi, V Verdi, A Vitale… - …, 2017 - pubmed.ncbi.nlm.nih.gov
Rationale In depressive disorders, one of the mechanisms proposed for antidepressant
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
V Di Liberto, M Frinchi, V Verdi, A Vitale… - …, 2017 - go.gale.com
Rationale In depressive disorders, one of the mechanisms proposed for antidepressant
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
V Di Liberto, M Frinchi, V Verdi, A Vitale… - …, 2016 - europepmc.org
Objectives Here, we aimed to explore (a) whether Oxo exerts anxiolytic effect in the rat
model of anxiety-depression-like behavior induced by chronic restraint stress (CRS), and (b) …
model of anxiety-depression-like behavior induced by chronic restraint stress (CRS), and (b) …
Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
V DI LIBERTO, M Frinchi, V Verdi, A Vitale… - …, 2017 - iris.unipa.it
Rationale: In depressive disorders, one of the mechanisms proposed for antidepressant
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
[PDF][PDF] Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the …
V Di Liberto, M Frinchi, V Verdi, A Vitale… - …, 2017 - academia.edu
Rationale In depressive disorders, one of the mechanisms proposed for antidepressant
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …
drugs is the enhancement of synaptic plasticity in the hippocampus and cerebral cortex …